BMY — Bristol-Myers Squibb Company stock price and chart

Share this page

BMY

$58.81-3.83%

as of close, Oct 5, 2026

☾ AH $58.81 -3.83%

Bristol-Myers Squibb CompanyStock · HealthcareS&P 500 Equal Weight 0.2%S&P 500 0.2%Russell 1000 0.2%US Stock Market 0.2%Russell 3000 0.2%MSCI ACWI 0.1%MSCI World 0.1%

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDED

20162019202120242026

45.050.055.060.065.070.075.00200.0M$58.81

2026-10-05

Price$58.81

MA20$60.36

MA50$55.40

Vol55.8M

What would $1,000 invested in BMY be worth today? →

BMY returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $58.81
YTD price return: +9.03%
YTD total return: +13.88%
Next earnings: Oct 29, 2026 · Before open
Market cap: 120.1B2016-12 97.7B2026-10 120.1B+23.0% over the window
Enterprise value: 156.3B
Shares outstanding: 2B2016-06 1.7B2026-06 2B+22.3% over the window
52W low: $42.52
52W high: $68.64
From 52W high: -14.32%
From 52W low: +38.31%
52W range: 62%
Beta: 0.23

Volume

Rel volume: 1.77×
30D volume: 10.8M
30D $ vol: 688.7M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1M0 insider-days of buying (no priced lot) and 1 of selling ($403K) in the last 30 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$403K
Insider net 3M0 insider-days of buying (no priced lot) and 2 of selling ($437K) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$437K
Insider net 1Y0 insider-days of buying (no priced lot) and 3 of selling ($2.3M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$2.3M

Form 4 transactions by trade date, as filed; latest on file 2026-09-09.

Fundamentals

Sales (ttm): 49.2B2016-06 17.6B2026-06 49.2B+179.2% over the window
Sales/share: $24.082016-06 $10.542026-06 $24.08+128.4% over the window
EPS (ttm): $4.542016-06 $1.702026-06 $4.54+167.2% over the window
FCF (ttm): 11.4B2016-06 597M2026-06 11.4B+1816.2% over the window
FCF/share: $5.602016-06 $0.362026-06 $5.60+1467.4% over the window
Book value/share: $10.932016-06 $8.932026-06 $10.93+22.4% over the window
Net margin: 18.87%2016-06 16.3%2026-06 18.9%+15.8% over the window
ROE: 41.59%2016-06 19.2%2026-06 41.6%+116.2% over the window
ROA: 10.59%2016-06 8.7%2026-06 10.6%+21.2% over the window
Debt / equity: 1.89×2016-06 0.442026-06 1.89+327.5% over the window
Current ratio: 1.532016-06 1.562026-06 1.53-1.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +3.11%2025-06-30 → 2026-06-3047.7B → 49.2B (+3.1% total)+2.87%2023-06-30 → 2026-06-3045.2B → 49.2B (+8.8% total)+2.08%2021-06-30 → 2026-06-3044.4B → 49.2B (+10.8% total)+10.81%2016-06-30 → 2026-06-3017.6B → 49.2B (+179.2% total)
Net income: +83.92%2025-06-30 → 2026-06-305B → 9.3B (+83.8% total)+5.24%2023-06-30 → 2026-06-308B → 9.3B (+16.6% total)n/a+12.46%2016-06-30 → 2026-06-302.9B → 9.3B (+223.4% total)
FCF: -21.54%2025-06-30 → 2026-06-3014.6B → 11.4B (-21.5% total)+2.19%2023-06-30 → 2026-06-3010.7B → 11.4B (+6.7% total)-0.43%2021-06-30 → 2026-06-3011.7B → 11.4B (-2.1% total)+34.36%2016-06-30 → 2026-06-30597M → 11.4B (+1816.2% total)
Shares: +0.36%2025-06-30 → 2026-06-302B → 2B (+0.4% total)-0.75%2023-06-30 → 2026-06-302.1B → 2B (-2.2% total)-1.67%2021-06-30 → 2026-06-302.2B → 2B (-8.1% total)+2.03%2016-06-30 → 2026-06-301.7B → 2B (+22.3% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +83.15%2025-06-30 → 2026-06-30$2.48 → $4.54 (+83.1% total)+6.56%2023-06-30 → 2026-06-30$3.75 → $4.54 (+21.0% total)n/a+10.33%2016-06-30 → 2026-06-30$1.70 → $4.54 (+167.2% total)
Sales/share: +2.74%2025-06-30 → 2026-06-30$23.44 → $24.08 (+2.7% total)+3.64%2023-06-30 → 2026-06-30$21.63 → $24.08 (+11.3% total)+3.81%2021-06-30 → 2026-06-30$19.97 → $24.08 (+20.6% total)+8.61%2016-06-30 → 2026-06-30$10.54 → $24.08 (+128.4% total)
FCF/share: -21.82%2025-06-30 → 2026-06-30$7.16 → $5.60 (-21.8% total)+2.96%2023-06-30 → 2026-06-30$5.13 → $5.60 (+9.1% total)+1.26%2021-06-30 → 2026-06-30$5.26 → $5.60 (+6.5% total)+31.68%2016-06-30 → 2026-06-30$0.36 → $5.60 (+1467.4% total)
Book value/share: +27.58%2025-06-30 → 2026-06-30$8.57 → $10.93 (+27.6% total)-10.62%2023-06-30 → 2026-06-30$15.30 → $10.93 (-28.6% total)-7.99%2021-06-30 → 2026-06-30$16.56 → $10.93 (-34.0% total)+2.04%2016-06-30 → 2026-06-30$8.93 → $10.93 (+22.4% total)
Dividend/share: +2.03%2025-06-30 → 2026-06-30$2.46 → $2.51 (+2.0% total)+3.71%2023-06-30 → 2026-06-30$2.25 → $2.51 (+11.6% total)+5.51%2021-06-30 → 2026-06-30$1.92 → $2.51 (+30.7% total)+5.21%2016-06-30 → 2026-06-30$1.51 → $2.51 (+66.2% total)
Price: +30.40%2025-10-06 → 2026-10-05$45.14 → $58.81 (+30.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.39%2023-10-05 → 2026-10-05$56.42 → $58.81 (+4.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.12%2021-10-05 → 2026-10-05$59.15 → $58.81 (-0.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.63%2016-10-04 → 2026-10-05$55.21 → $58.81 (+6.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +36.22%2025-10-06 → 2026-10-05$43.22 → $58.81 (+36.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+6.28%2023-10-05 → 2026-10-05$48.98 → $58.81 (+20.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.11%2021-10-05 → 2026-10-05$48.09 → $58.81 (+22.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.35%2016-10-04 → 2026-10-05$38.42 → $58.81 (+53.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 12.9×2016-12 29.022026-10 12.94-55.4% over the window
Fwd P/E: 9.3×
P/S (ttm)Market cap ÷ TTM revenue.: 2.4×2016-12 5.292026-10 2.44-53.8% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 5.4×2016-12 6.262026-10 5.38-14.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 10.5×2016-12 71.292026-10 10.50-85.3% over the window
EV/EBITDA (fy): 9.3×
EV/Sales (ttm): 3.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 9.52%2016-09 1.4%2026-06 9.7%+588.7% over the window
Dividend yield (fwd)Indicated annual dividend ÷ last close: the last regular payment × payments a year, from our own dividend record. Shown only for a company that pays the same amount each time (raises and cuts allowed), whose payments are on schedule and agree with the dividends it reports paying; a company whose payments vary in size, such as an unequal interim and final, has no forward figure — see the ttm yield.: 4.28%
Dividend yield (ttm)Dividends paid over the last year ÷ last close: the last full cycle of regular payments in our own dividend record. Below the forward yield after a raise, above it after a cut. Shown only when the record holds that full cycle and it agrees with the dividends the company reports paying; otherwise —.: 4.28%
Dividend/share (fwd)The indicated annual dividend: the last regular payment × payments a year, for a company that pays the same amount each time.: $2.52
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 2.04B ÷ 2.04B. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.36%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.36%) + dividends paid over that year ($5.1B) ÷ market_cap_at(2025-06-30) ($94.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 5.05%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($120.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 0.2%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $5.1B) ÷ today's market cap ($120.1B). Same caveat as the cash buyback yield.: 4.24%2016-09 2.8%2026-06 4.3%+52.2% over the window

Vs own 10Y history

P/E: 7th
P/S: 22nd
P/B: 55th
P/FCF: 38th

Bar = where today’s multiple sits in BMY’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-05#

-3.83%

-7.94%

-11.99%

+1.17%

YTD

+9.03%

+29.39%

-0.57%

Recent filings#

Sep 9Insider sale · Massacesi Cristian (EVP,Chief Med Offr,Head of Dev) sold 6,249 shares for $403K at $64.57
Aug 25Insider sale · Holzer Phil M (SVP and Controller) sold 500 shares for $34K at $67.50
Jul 30Earnings · Earnings release — EPS $2.04 vs $1.59 est. (+28.3%); revenue $12.97B (+6% y/y) 2.8%
Jul 30Report · Quarterly report, Q2 2026 — revenue $12.97B (+6% y/y), net income $3.32B, EPS $1.62

All filings and insider trades →

Financial statements

Open full BMY financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-0.54%	+0.02%
JNJ	Johnson & Johnson	-8.10%	-1.21%
ABBV	AbbVie Inc.	+3.63%	+1.12%
MRK	Merck & Co. Inc.	-7.18%	-3.30%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.67%	+1.80%
TMO	Thermo Fisher Scientific Inc.	+10.26%	+3.35%
AMGN	Amgen Inc.	-7.83%	-0.01%
GILD	Gilead Sciences Inc.	-4.22%	-0.08%

BMY — Bristol-Myers Squibb Company price, chart and key statistics